CASSIDY TUCKER: Open Payments
NPI 1770270399 · CLIO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 69 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $464 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $253 |
| Vanda Pharmaceuticals Inc. | 9 | $233 |
| Novo Nordisk Inc | 9 | $136 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| Exact Sciences Corporation | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| PFIZER INC. | 4 | $69 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Lundbeck LLC | 3 | $54 |
Products named: FANAPT, VRAYLAR, REXULTI, Auvelity, Wegovy, NURTEC ODT, Ozempic, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
